Top

Indian Journal of Otolaryngology and Head & Neck Surgery

Published in:

01-10-2019 | Oral Cancer | Original Article

Biomarkers in Head and Neck Cancer an Update

Authors: Naveed Basheeth, Naishadh Patil

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Special Issue 1/2019

Abstract

The study is aimed at establishing the purpose of tumour markers, their application, classification, diagnostic and therapeutic roles in the management of head and neck cancer. A literature review using Medline, Scopus, Google Scholar, the Cochrane Database of Systematic Reviews and the Cochrane central register of controlled trials for articles published between 1993 and 2016 on tumour markers and their role in head and neck cancer was performed. A broader search of prognostic markers in head and neck cancer was also carried out to avoid missing other pertinent markers. Natural history, tumour biology, stage and prognostic factors influence the outcome of management in patients with Head and Neck Squamous cell carcinoma (HNSCC). Evaluation of the cellular lineage and histogenic origin of diverse neoplasms can be done using tumour biomarkers. Identifying predictive tumour markers can lead to improvement in preventive management of HNSCC. There has been remarkable advancement in molecular technology with gene expression and proteomic profiling. Integration of specific tumour markers into routine clinical practice requires substantiation through well designed clinical trials. The investigation of tumour markers is imperative as they influence the prognosis of HNSCC and provide the potential to improve outcomes of treatment through targeted therapy. We have outlined recent tumour biomarkers in this review which have significant role in diagnosis, screening and prognostication in HNSCC. Recent advancement in clinical applications, therapeutic strategies of tumour markers has been highlighted.

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55:74–108PubMedCrossRef

Schaaij-Visser TB, Brakenhoff RH, Leemans CR, Heck AJ, Slijper M (2010) Protein biomarker discovery for head and neck cancer. J Proteomics 73(10):1790–1803PubMedCrossRef

http://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ucm301431.htm

Chan DW, Sell S (1994) Tumor markers. In: Burtis CA, Ashwood ER (eds) Tietz’s textbook of clinical chemistry, 2nd edn. WB Saunders, Philadelphia, pp 897–925

Nayak AG, Chatra L (2010) Tumour markers: an overview. J Indian Acad Oral Med Radiol 3:147–150CrossRef

Lutzky VP, Moss DJ, Chin D, Coman WB, Parsons PG, Boyle GM (2008) Biomarkers for cancers of the head and neck. Clin Med Ear Nose Throat 1:5–15CrossRef

Rodrigo JP, Ferlito A, Suárez C, Shaha AR, Silver CE, Devaney KO, Bradley PJ, Bocker JM, McLaren KM, Grénman R, Rinaldo A (2005) New molecular diagnostic methods in head and neck cancer. Head Neck 11:995–1003CrossRef

Lee KD, Lee HS, Jeon CH (2011) Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. Anticancer Res 4:1161–1167

Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ (2004) Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 10:3607–3613PubMedCrossRef

10.

Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB (1994) Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73:187–190PubMedCrossRef

11.

Sanjay Reddy B, Madhavi Reddy B, Shyam NDVN (2010) Tumour markers in oral neoplasia. Indian J Dental Adv 2(1):103Y114

12.

Anil S, Beena VT, Nair RG, Vijayakaumar T (1995) Evaluation of serum beta 2-microglobulin in premalignant and malignant lesions of the oral cavity. Oral Srug Oral Med Oral Pathol Oral Radiol Endod 79(6):750–752CrossRef

13.

Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H (1999) Syndecan-1 expression as prognostic significance in head and neck carcinoma. Br J Cancer 79(3–4):558–564PubMedPubMedCentralCrossRef

14.

Scully C, Burkhardt A (1993) Tissue markers of potentially malignant human oral epithelial lesions. J Oral Pathol Med 22:246–256PubMedCrossRef

15.

Schliephake H (2003) Prognostic relevance of molecular markers of oral cancer- a review. Int J Oral Maxillofac Surg 32:233–245PubMedCrossRef

16.

Chimenos-Küstner E, Font-Costa I, López-López J (2004) Oral cancer risk and molecular markers. Med Oral Patol Oral Cir Buccal 9:377–384

17.

Wreesmann VB, Singh B (2012) Molecular biology as applied to head and neck oncology. In: Watkinson JC, Gilbert RW (eds) Stell and maran’s textbook of head and neck surgery and oncology, 5th edn. CRC Press, Boca Raton, pp 24–34

18.

Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282–3287PubMed

19.

Zeka A, Gore R, Kriebel D (2003) Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 14:897–906PubMedCrossRef

20.

Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 18(2):542–550CrossRef

21.

Quon H, Liu FF, Cummings BJ (2001) Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 23(2):147–159PubMedCrossRef

22.

Coulombe PA, Omary MB (2002) ‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14(1):110–122PubMedCrossRef

23.

Grandis JR, Tweardy DJ (1993) Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579–3584PubMed

24.

Rubin Grandis J, Melhem MF, Gooding WE et al (1998) Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90:824–832PubMedCrossRef

25.

Thomas SM, Grandis JR (2009) The current state of head and neck cancer gene therapy. Hum Gene Ther 2009(20):1565–1575CrossRef

26.

Langer CJ (2012) Exploring biomarkers in head and neck cancer. Cancer 118(16): 3882–92. https://doi.org/10.1002/cncr.26718. Epub (2012) Review erratum in: cancer 118(23): 6014PubMedCrossRef

27.

Yavrouian EJ, Sinha UK (2012) Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma. ISRN Surg: 715743

28.

Ogden GR, Chisholm DM, Adl M, Lane EB (1993) Cytokeratin expression in oral cancer and its relationship to tumour differentiation. J Oral Pathol Med 2:82–86CrossRef

29.

Okamura K, Kiyoshima T, Shima K, Kobayashi I, Matsyo K, Ishibashi H, Komatsu S, Rasul AM, Sakai H (2002) Immunohistochemical expression of CA 19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland. Oral Oncol 38(3):244–250PubMedCrossRef

30.

Oliver RJ, Mac Donald DG (2000) Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions. J Oral Pathol Med 29(9):426–431PubMedCrossRef

31.

Karamouzis MV, Grandis JR, Argiris A (2007) Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. JAMA 298:70–82PubMedCrossRef

32.

Le Tourneau C, Siu LL (2008) Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck. Curr Opin Oncol 20:256–263PubMedCrossRef

33.

Rassam MB, al-Bashir NN, al-saiihi AR, Hammash MH, al-Sammeral FT, al-Ubaidi MA, Waheed IN (1995) Heat stable alkaline phosphatase. A putative tumour marker of head and neck squamous cell carcinoma. Acta Oncol 34(1):49–52PubMedCrossRef

34.

Therkilden MH, Mandel U, Christensen M, Dabelsteen E (1993) Simple mucin type Tn and siaosyl-Tn carbohydrate antigens in salivary gland carcinomas. Cancer 72(4):1147–1154CrossRef

35.

Takes RP (2004) Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol 40:656–667PubMedCrossRef

36.

Kanke M, Fujii M, Kameyama K, Kanzaki J, Tokumaru Y, Imanishi Y et al (2000) Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 126(10):1217–1223PubMedCrossRef

37.

Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA (1996) Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 122(6):627–632PubMedCrossRef

38.

Masuda M, Kuratomi Y, Shiratsuchi H, Nakashima T, Naonobu K, Komiyama S (2000) Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy. Head Neck 22(7):662–665PubMedCrossRef

39.

Cullen KJ, Schumaker L, Nikitakis N et al (2009) Beta-tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. J Clin Oncol 27:6222–6228PubMedCrossRef

40.

John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT (2004) Interleukin-6 and interleukin- 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:929–935CrossRef

41.

Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E (2008) Expression of melanoma-associated antigens in oral squamous cell carcinoma. J Oral Pathol Med 37:88–93PubMedCrossRef

42.

Büntzel J, Hornig A, Glatzel M, Micke O, Bruns F, Schäfer U, Fröhlich D (2005) Tumor markers and lymphatic metastasis in head and neck cancer patients. Anticancer Res 3A:1539–1542

43.

Hou Y, Li C (2013) Chemokine receptors as biomarkers in head and neck squamous cell carcinoma. J Oncobiomarkers 1(1):2

44.

Hiyama T, Yoshihara M, Tanaka S, Chayama K (2008) Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol 32:945–973PubMed

45.

Hopkins J, Cescon DW, Tse D et al (2008) Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev 17:490–499PubMedCrossRef

46.

Marsit CJ, Posner MR, McClean MD, Kelsey KT (2008) Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer 113(7):1566–1571PubMedCrossRef

47.

Vaezi AE, Bepler G, Bhagwat NR, Malysa A, Rubatt JM, Chen W, Hood BL, Conrads TP, Wang L, Kemp CE, Niedernhofer LJ (2014) Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas. Cancer 120(12):1898–1907PubMedCrossRef

48.

Hwang S, Mahadevan S, Qadir F, Hutchison IL, Costea DE, Neppelberg E, Liavaag PG, Waseem A, Teh MT (2013) Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas. Cancer 119(24):4249–4258PubMedCrossRef

49.

Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR, Freilino M, Sauerwein S, Peyser ND, Xiao D, Diergaarde B, Wang L, Chiosea S, Seethala R, Johnson JT, Kim S, Duvvuri U, Ferris RL, Romkes M, Nukui T, Kwok-Shing Ng P, Garraway LA, Hammerman PS, Mills GB, Grandis JR (2013) Frequent mutation of the PI3 K pathway in head and neck cancer defines predictive Biomarkers. Cancer Discov 7:761–769CrossRef

50.

Teixeira MS, Camacho-Vanegas O, Fernandez Y, Narla G, DiFeo A, Lee B, Kalir T, Friedman SL, Schlecht NF, Genden EM, Urken M, Brandwein-Gensler M, Martignetti JA (2007) KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma. Int J Cancer 121(9):1976–1983PubMedCrossRef

51.

Rennemo E, Z¨atterstr¨om U, Boysen M (2008) Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 118(8):1350–1356PubMedCrossRef

52.

53.

Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467–475PubMedCrossRef

54.

Chaturvedi A, Engels E, Anderson W, et al. (2007) Incidence trends for human papillomavirus-related (HPV-R) and unrelated (HPV-U) head and neck squamous cell carcinomas (HNSCC) in the United States (US) [abstract]. J Clin Oncol 25(suppl). Abstract 6001

55.

Perez-Ordonez B, Beauchemin M, Jordan RC (2006) Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59:445–453PubMedPubMedCentralCrossRef

56.

Fakhry C, Westra WH, Li S et al (2008) Improved survival of patient with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 1000:261–269CrossRef

57.

Munger K, Howley PM (2002) Human papillomavirus immortalization and transformation functions. Virus Res 89:213–228PubMedCrossRef

58.

Hafkamp HC, Manni JJ, Haesvoets A et al (2008) Marked differences in survival rate between smokers and non-smokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 122(12):2656–2664PubMedCrossRef

59.

El-Naggar AK, Westra WH (2012) P16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 34:459–461PubMedCrossRef

60.

Singhi AD, Westra WH (2010) Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 116:2166–2173PubMed

61.

Lewis JS Jr (2012) P16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 6(Suppl. 1):S75–S82PubMedCrossRef

62.

Rooper LM, Gandhi M, Bishop JA, Westra WH (2016) RNA in situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in situ hybridization. Oral Oncol 55:11–16PubMedCrossRef

63.

Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O’Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T (2012) Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Mol Cell Proteomics 11:1404–1415PubMedPubMedCentralCrossRef

64.

Lucs AV, Saltman B, Chung CH, Steinberg BM, Schwartz DL (2013) Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment. Head Neck 35(2):294–306PubMedCrossRef

65.

Canil CM, Tannock IF (2002) Doctor’s dilemma: incorporating tumor markers into clinical decision-making. SeminOncol 29:286–293

Title: Biomarkers in Head and Neck Cancer an Update
Authors: Naveed Basheeth
Naishadh Patil
Publication date: 01-10-2019
Publisher: Springer India
Keywords: Oral Cancer
Biomarkers
Oral Cavity Carcinoma
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery / Issue Special Issue 1/2019
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-019-01683-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Biomarkers in Head and Neck Cancer an Update

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2019

A Review and Outcome of Adenoidectomy Performed in Resource Limited Settings

Maffucci Syndrome with Clival Enchondroma in Nasopharynx: A Case Report

Varied Presentation of Venous Ectasia Head and Neck: Case Series and Review of Literature

Evaluation of Dynamic CT Scans and Analyzing Its Efficacy Accuracy in Staging of Laryngeal CA: A Prospective Analysis of 30 Patients and Review of Literature

Study of Demographic Profile of Organophosphate Compound Poisoning with Special Reference to Early Versus Late Tracheostomy in Tertiary Care Hospital in Rural Area

Spontaneous Expulsion of an Unusual Sharp Metallic Foreign Body: A Rare Occurrence